Arnold R. Gammaitoni
Keine laufenden Positionen mehr
Profil
Arnold R.
Gammaitoni served as President-Scientific Affairs at Nuvo Pharmaceuticals, Inc. in 2012.
He then worked as Vice President-Medical & Scientific Affairs at Zogenix, Inc. from 2013 to 2023.
Gammaitoni holds a doctorate degree from the University of the Sciences in Philadelphia.
Ehemalige bekannte Positionen von Arnold R. Gammaitoni
Unternehmen | Position | Ende |
---|---|---|
ZOGENIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
NUVO PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Arnold R. Gammaitoni
University of the Sciences in Philadelphia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |